The situation reported by Novavax comes despite having posted huge sales gains over the past three years during the height of the pandemic.
However, the company posted a loss of $658 million in 2022.
Novavax, one of the big vaccine makers in the pandemic, acknowledges financial problems
2023-03-02T21:23:09.766Z
The situation reported by Novavax comes despite having posted huge sales gains in the last three years during the heyday of the | Economy | CNN